Guan, X., Shi, Y., Yang, J., Xu, F., Li, H., Wang, W., Wu, X., Zhou, X., Liu, Y., Yu, H., Guo, W., Tang, H., Tian, X., Zhou, Y., Wei, Z. (2025). A phase II study to evaluate the safety and efficacy of BB-1701 in subjects with HER2 expression locally advanced/metastatic breast cancer previously treated with HER2-ADC containing TOP-I inhibitor.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.1093